EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

An Innovative Screening Panel for Preventing Miscarriages—Perspectives, Guidance and Guidelines

Wioleta Justyna Omeljaniuk iD

Antioxidants · 09.04.2026 · 15 (4) · 464

DOI: 10.3390/antiox15040464 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Antioxidants, online erschienen am 09.04.2026. Verfasst von Wioleta Justyna Omeljaniuk. Beteiligte Einrichtung: Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-222 Bialystok, Poland. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Miscarriage is the most common complication of pregnancy. Current trends in medicine point to the increasing importance of evidence-based personalization in diagnostic and therapeutic processes.

Purpose

The aim of this study was to develop an innovative prenatal screening panel and treatment strategy for miscarriage prevention.

Results

Previous studies have demonstrated an imbalance between oxidative and anti-oxidant mechanisms, resulting in systemic oxidative stress in women with a history of miscarriage. The importance of monitoring toxic metal concentrations as potential risk factors in early pregnancy was confirmed. The involvement of NETs in the pathogenesis of miscarriages was demonstrated, while identifying early biomarkers of this process. The effect of BPA on the activation of NETs and the development of an inflammatory response in the female participants was demonstrated. Furthermore, a mechanism of NO-dependent oxidative–anti-oxidative imbalance and NLRP3 inflammasome activation during pregnancy loss was identified in a pathway independent of NET formation, excluding apoptosis. The participation of certain microRNA molecules in reproductive failure and their value in minimally invasive diagnostics in the early stages of pregnancy have been proven.

Conclusions

The proposed screening panel accounts for the above parameters, represents a novel approach in modern prenatal care, and prioritizes miscarriage prevention strategies.

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiagnostic potentialmiscarriageprenatal carescreening panel

Autor:innen und Institutionen

  • Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-222 Bialystok, Poland.

ORCID-Profile: Wioleta Justyna Omeljaniuk

Zitieren

APA

Omeljaniuk, W. J. (2026). An Innovative Screening Panel for Preventing Miscarriages—Perspectives, Guidance and Guidelines. Antioxidants, 15(4), 464. https://doi.org/10.3390/antiox15040464

Vancouver

Omeljaniuk WJ. An Innovative Screening Panel for Preventing Miscarriages—Perspectives, Guidance and Guidelines. Antioxidants. 2026;15(4):464. doi:10.3390/antiox15040464

BibTeX
@article{Omeljaniuk2026,
  author = {Omeljaniuk, Wioleta Justyna},
  title = {An Innovative Screening Panel for Preventing Miscarriages—Perspectives, Guidance and Guidelines},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {464},
  doi = {10.3390/antiox15040464}
}
Kostenlos starten →